Profile for morritanoso
|
SignatureAetna considers denosumab (Prolia and Xgeva) contraindicated and considered experimental and investigaitonal for persons with uncorrected preexisting hypocalcemia, because the safety and effectiveness of denosumab for hypocalcemic persons has not been established.
|